Watch past educational presentations and see live events in real time
Reference our medication guides for helpful information
Explore available award and grant opportunities for fellows-in-training.
Make a choice that matters
The best care starts with the best information. See videos to help answer your questions.
The ACR is accepting applications for mini curriculums, which are educational activities or curriculums to enhance the ACR Core Curriculum Outline.
Sarilumab (Kevzara) is a biologic medication currently approved to treat adults with moderate to severe active rheumatoid arthritis (RA). Biologic medications are proteins designed by humans that affect the immune system. Sarilumab stops inflammation by blocking a molecule called interleukin-6 receptor (IL-6R) in the immune system. This improves joint pain and swelling from rheumatoid arthritis and other symptoms caused by inflammation.
For adults with RA, sarilumab is given as a self-adminstered subcutaneous (beneath the skin) injection every 2 weeks at a dose of 150 mg or 200 mg. The medicine can be injected into the thighor abdomen. The site of injection should be rotated so the same site is not used multiple times. Some patients will start to see improvement within a few weeks, but it may take several months to take full effect. Sarilumab may be taken alone or with methotrexate or other non-biologic drugs. Sarilumab should not be given in combination with another biologic drug. Blood tests will be used to monitor for changes to liver enzymes, cholesterol, and for reductions in blood cell counts while taking sarilumab.
Sarilumab can lower the ability of your immune system to fight infections. If you develop symptoms of an infection while using this medication, you should stop it and contact your doctor. All patients should be tested for tuberculosis before starting on sarilumab, although these types of infections have not been frequently seen. A rare complication seen with sarilumab use in clinical trials was bowel perforation, or a hole in the bowel wall. If you have a history or diverticulitis or develop abdominal pain or bloody bowel movements while taking sarilumab, you should notify your doctor immediately.
You should notify your rheumatology provider if you develop symptoms of an infection, such as a fever or cough, or if you think you are having any side effects, especially abdominal pain, bloody bowel movements, or allergic reactions. Notify your doctor if you become pregnant, are planning pregnancy, or if you are breastfeeding. Be sure to talk with your rheumatology provider if you are planning to have surgery or get any live vaccinations; these include shingles, nasal spray flu vaccine, measles, mumps, rubella, and yellow fever vaccines.
Updated December 2020 by Kristen Lee, MD, and reviewed by the American College of Rheumatology Committee on Communications and Marketing.
This information is provided for general education only. Individuals should consult a qualified health care provider for professional medical advice, diagnosis and treatment of a medical or health condition.